News
-
Joint ICPerMed and EP PerMed Conference – Recordings and Slides available
EP PerMed and the International Consortium for Personalised Medicine (ICPerMed) jointly organised a conference on the achievements in personalised medicine in the last decade on 26 and 27 November 2025 in Prague, Czech Republic. The slides and recordings of the live stream are now available.
-
EP PerMed JTC2026 Information Day – Recording & Slides available
With this JTC2026, EP PerMed will fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. On 16 December 2025, the research community was introduced to the JTC2026 during an information day that attracted more than 500 participants. The recording and slides are now available.
-
Research Infrastratures, Initiatives and Projects related to Personalised Medicine
As part of its mapping activities, EP PerMed has compiled a comprehensive list of European research infrastructures, as well as research and innovation projects and initiatives related to personalised medicine.
-
EMA Consultation on the Guideline Revision on Good Pharmacogenomic Practice
The European Medicines Agency (EMA) has opened an an online consultation on its concept paper on the revision of the guideline on good pharmacogenomic practice.
EP PerMed JTC2026
Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)
EP PerMed will fund research projects in human health on innovative personalised medicine strategies for patients with cardiovascular, metabolic or kidney diseases. Research projects may focus on a single disease or explore these conditions in combination. The available budget for this call is 38 Mio. € (approx.). Deadline for pre-proposal submission in 10 February 2026.
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
EP PerMed Podcast ‘The Science of You’
The second season of the EP PerMed podcast tells four powerful stories of patients and former patients who have benefited from personalised medicine. With topics ranging from oncology and rare genetic disorders to preventive surgery and cardiovascular diseases, this season illustrates real human experiences, showing how tailored therapies are transforming the treatment process into a more effective and informed one.